Sign in

CIK 0001729427

  • Non-accelerated filer
  • Smaller reporting company

CNS Pharmaceuticals, Inc.

Sign in to watch
Ticker
CNSP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
822318545
Phone
+1 800-946-9185
Business address
2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-17 Downs Christopher Chief Financial Officer Grant or award · Option to purchase common stock +4,881 4,881
2024-04-08 Downs Christopher Chief Financial Officer Grant or award · Option to purchase common stock +40,000 201.57
2024-04-08 Downs Christopher Chief Financial Officer Grant or award · Restricted Stock Units +40,000 241.57
2024-02-01 Downs Christopher Chief Financial Officer Purchase +66,666 $0.30 $20K 103,438
2024-02-01 Downs Christopher Chief Financial Officer Grant or award · Series A Warrant to purchase common stock +66,666 94,906
2024-02-01 Downs Christopher Chief Financial Officer Grant or award · Series B Warrant to purchase common stock +66,666 161,572
2023-08-22 Downs Christopher Chief Financial Officer Purchase +27,000 $1.27 $34K 36,772
2023-04-28 Downs Christopher Chief Financial Officer Exercise or conversion +521 9,772
2023-04-28 Downs Christopher Chief Financial Officer Exercise or conversion · Restricted Stock Units −521 28,248
2023-04-17 Downs Christopher Chief Financial Officer Purchase +3,100 $3.20 $10K 9,251
2023-03-29 Downs Christopher Chief Financial Officer Grant or award · Restricted Stock Units +6,067 28,768
2022-04-28 Downs Christopher Chief Financial Officer Grant or award · Restricted Stock Units +250,000 681,000
2022-03-11 Downs Christopher Chief Financial Officer Grant or award +33,000 $0.31 $10K 184,500
2021-12-06 Downs Christopher Chief Financial Officer Purchase +5,000 $0.94 $5K 151,500
2021-11-19 Downs Christopher Chief Financial Officer Purchase +4,500 $1.15 $5K 146,500
2021-02-05 Downs Christopher Chief Financial Officer Grant or award · Option to purchase common stock (right to buy) +131,000 431,000
2020-08-24 Downs Christopher Chief Financial Officer Purchase +142,000 $2.04 $290K 142,000
2019-11-13 Downs Christopher Chief Financial Officer Grant or award · Option to purchase common stock (right to buy) +300,000 300,000

Page 1 of 1 · 18 trades